Targeted liposomal drug delivery in cancer - PubMed (original) (raw)
Review
Targeted liposomal drug delivery in cancer
Oula Penate Medina et al. Curr Pharm Des. 2004.
Abstract
Liposomes, which are biodegradable and essentially non-toxic vehicles, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery systems. In addition, liposomes can be used to carry radioactive compounds as radiotracers can be linked to multiple locations in liposomes. One option is the hydrated compartment inside the liposome, another the lipid core into which especially hydrophobic conjugates can be attached, and the third option is the outer lipid leaflet where molecules can be bound by covalent linkage. Delivery of agents to the reticuloendothelial system (RES) is easily achieved, since most conventional liposomes are trapped by the RES. For the purpose of delivery of agents to target organs other than RES, long-circulating liposomes have been developed by modifying the liposomal surface. Understanding of the in vivo dynamics of liposome-carried agents is required for the evaluation of the bioavailability of drugs encapsulated in liposomes. In this review, we focus on the in vivo trafficking of liposomes visualized by positron emission tomography (PET) and discuss the characteristics of liposomes that affect the targeting of drugs in vivo.
Similar articles
- Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y, Taguchi K, Yamasaki K, Sakuragi M, Kuroda S, Otagiri M. Okamoto Y, et al. J Pharm Sci. 2018 Jan;107(1):436-445. doi: 10.1016/j.xphs.2017.08.003. Epub 2017 Aug 18. J Pharm Sci. 2018. PMID: 28826882 - Liposomal Nanotechnology for Cancer Theranostics.
Yue X, Dai Z. Yue X, et al. Curr Med Chem. 2018;25(12):1397-1408. doi: 10.2174/0929867324666170306105350. Curr Med Chem. 2018. PMID: 28266269 Review. - Long-circulating liposomes.
Oku N, Namba Y. Oku N, et al. Crit Rev Ther Drug Carrier Syst. 1994;11(4):231-70. Crit Rev Ther Drug Carrier Syst. 1994. PMID: 7664348 Review. - Liposomal Delivery Systems: Design Optimization and Current Applications.
Abu Lila AS, Ishida T. Abu Lila AS, et al. Biol Pharm Bull. 2017;40(1):1-10. doi: 10.1248/bpb.b16-00624. Biol Pharm Bull. 2017. PMID: 28049940 Review. - Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
Oku N, Namba Y. Oku N, et al. Methods Enzymol. 2005;391:145-62. doi: 10.1016/S0076-6879(05)91008-2. Methods Enzymol. 2005. PMID: 15721379
Cited by
- Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Immordino ML, Dosio F, Cattel L. Immordino ML, et al. Int J Nanomedicine. 2006;1(3):297-315. Int J Nanomedicine. 2006. PMID: 17717971 Free PMC article. Review. - Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system.
Medina OP, Pillarsetty N, Glekas A, Punzalan B, Longo V, Gönen M, Zanzonico P, Smith-Jones P, Larson SM. Medina OP, et al. J Control Release. 2011 Feb 10;149(3):292-8. doi: 10.1016/j.jconrel.2010.10.024. Epub 2010 Nov 1. J Control Release. 2011. PMID: 21047536 Free PMC article. - Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.
Li H, Piao L, Xu P, Ye W, Zhong S, Lin SH, Kulp SK, Mao Y, Cho Y, Lee LJ, Lee RJ, Lin YC. Li H, et al. Pharm Res. 2011 Dec;28(12):3256-64. doi: 10.1007/s11095-011-0498-2. Epub 2011 Jun 28. Pharm Res. 2011. PMID: 21710341 Free PMC article. - Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).
Spuch C, Navarro C. Spuch C, et al. J Drug Deliv. 2011;2011:469679. doi: 10.1155/2011/469679. Epub 2011 Dec 13. J Drug Deliv. 2011. PMID: 22203906 Free PMC article. - Adhesive interactions between cells and biotinylated phospholipid vesicles in alginate: towards new responsive biomaterials.
de Cogan F, Gough JE, Webb SJ. de Cogan F, et al. J Mater Sci Mater Med. 2011 Apr;22(4):1045-51. doi: 10.1007/s10856-011-4271-1. Epub 2011 Mar 23. J Mater Sci Mater Med. 2011. PMID: 21431355
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources